Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket

Loading...
Loading...

Gainers

  • HHG Capital Corporation HHGC shares rose 42.1% to $14.56 in pre-market trading.
  • Rubius Therapeutics, Inc. RUBY rose 32% to $0.60 in pre-market trading after declining 7% on Thursday. Rubius Therapeutics recently discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
  • T2 Biosystems, Inc. TTOO rose 18% to $0.1055 in pre-market trading after the company announced a distribution agreement in the Baltic Region. The company will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through the distributor.
  • Aqua Metals, Inc. AQMS rose 15.9% to $0.98 in pre-market trading.
  • Ampio Pharmaceuticals, Inc. AMPE rose 15.2% to $0.09 in pre-market trading.
  • Avenue Therapeutics, Inc ATXI rose 13.2% to $7.47 in pre-market trading. Avenue Therapeutics shares gained 106% on Thursday after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23.
  • Ventoux CCM Acquisition Corp. PRST rose 12.6% to $5.63 in pre-market trading.
  • Snow Lake Resources Ltd. LITM rose 10.9% to $2.55 in pre-market trading.
  • Alaunos Therapeutics, Inc. TCRT rose 10.6% to $2.08 in pre-market trading. Alaunos Therapeutics recently announced early clinical data from the first patient in its ongoing TCR-T Library Phase 1/2 trial.
  • VEON Ltd. VEON rose 10.6% to $0.4095 in pre-market trading.
  • Kiora Pharmaceuticals, Inc. KPRX rose 10.1% to $0.23 in pre-market trading after surging around 23% on Thursday.
  • NextPlay Technologies, Inc. NXTP rose 8.6% to $0.24 in pre-market trading.
  • American Virtual Cloud Technologies, Inc. AVCT rose 6.4% to $0.3317 in pre-market trading after surging around 45% on Thursday.

 

Don’t forget to check out our premarket coverage here .

Losers

  • Splash Beverage Group, Inc. SBEV rose 17.5% to $1.60 in pre-market trading after the company reported a proposed underwritten public offering of common stock.
  • Spectrum Pharmaceuticals, Inc. SPPI fell 14.1% to $0.5448 in pre-market trading after the FDA Oncologic Drugs Advisory Committee voted 9-4 that the current benefits of poziotinib did not outweigh its risks.
  • Nisun International Enterprise Development Group Co., Ltd NISN fell 12.3% to $0.50 in pre-market trading after declining around 10% on Thursday.
  • Neptune Wellness Solutions Inc. NEPT shares fell 12.2% to $1.51 in pre-market trading after declining 7% on Thursday.
  • Cellectis S.A. CLLS fell 11.5% to $2.37 in pre-market trading. Cellectis, last month, posted a Q2 loss of $0.36 per share.
  • Panbela Therapeutics, Inc. PBLA fell 10.2% to $0.3189 in pre-market trading after surging over 46% on Thursday.
  • Sphere 3D Corp. ANY fell 9.8% to $0.4870 in pre-market trading. Sphere 3D recently provided Bitcoin production and mining updates for August 2022.
  • BitNile Holdings, Inc. NILE fell 8.2% to $0.1855 in pre-market trading after declining 4% on Thursday.
  • Taseko Mines Limited TGB shares fell 7% to $1.20 in pre-market trading.
  • Credit Suisse Group AG CS fell 6.6% to $4.40 in pre-market trading. Credit Suisse denied that it is exiting the US market, Bloomberg said.
  • ShiftPixy, Inc. PIXY shares fell 6.5% to $17.75 in pre-market trading after jumping 39% on Thursday. ShiftPixy, on Wednesday, announced pricing of $5 million private placement.
  • Edap Tms SA EDAP shares fell 5.6% to $8.09 in pre-market trading after the company reported pricing of public offering of American Depositary Shares.
  • Standard Lithium Ltd. SLI fell 5.1% to $4.45 in pre-market trading. bluebird bio shares jumped over 15% on Tuesday after Raymond James maintained an Outperform rating on the stock and raised its price target from $8 to $10.
  • Costco Wholesale Corporation COST fell 3.1% to $472.38 in pre-market trading. Costco reported better-than-expected results for its fiscal fourth quarter on Thursday.
  • FedEx Corporation FDX fell 1.3% to $152.50 in pre-market trading. FedEx said its adjusted earnings per share dropped to $3.44 for the quarter ended Aug 31 compared to $4.37 in the year-ago period, while revenue increased to $23.2 billion from $22 billion. FedEx also announced plans to repurchase $1.5 billion of its common stock during fiscal 2023. The company said it plans to repurchase $1 billion of its common stock in the second quarter.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasCommunications EquipmentInformation TechnologyPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...